期刊文献+

调节性T细胞与肺癌关系的研究进展 被引量:4

Research progress on relationship between regulatory T cells and lung cancer
原文传递
导出
摘要 CD+4 CD+25 Foxp3+ 调节性T(Treg)细胞是抑制性T细胞的一种亚群,能够强有力地抑制效应T淋巴细胞的活化、增生及功能,Treg细胞在防止自身免疫、介导移植耐受等方面发挥着重要作用。Treg细胞在肺癌组织及患者外周血中含量明显增高,与肺癌的临床分期及肺癌类型密切相关。Treg细胞对于肺癌临床诊断以及治疗有重要意义。 As a subset of Inhibitory T cells, CD+4 CD+25 Foxp3+ regulatory T (Treg) cells could strongly inhibit the activation, proliferation and function of effector T lymphocytes cells.Treg cells play an important role in downregulate autoimmune and mediating transplantation tolerance. Treg cells concerntrations could be markedly increased expression in tumor issues and peripheral blood of lung cancer. The clinical staging of lung cancer and lung cancer pathological types. Treg cells are important for lung cancer diagnosis and treatment.
出处 《肿瘤研究与临床》 CAS 2013年第1期62-65,共4页 Cancer Research and Clinic
关键词 调节性T细胞 肺肿瘤 肿瘤逃逸 Regulatory T cells Lung neoplasms Tumor escape
  • 相关文献

参考文献9

二级参考文献111

  • 1何建军,任予,王一理.CD4^+CD25^+调节性T细胞在肿瘤免疫领域的研究进展[J].现代肿瘤医学,2004,12(5):478-479. 被引量:4
  • 2刘莉,丁乾,曹如波,王晶,姚军霞,黄士昂.恶性肿瘤患者外周血CD4^+ CD25^+调节T细胞的检测及其临床意义[J].临床肿瘤学杂志,2005,10(4):342-345. 被引量:16
  • 3刘荣军,葛棣,丁建勇,熊思东,赵强,张镭,储以微.肺癌患者CD4^+ CD25^(high) Foxp3^+调节性T细胞的格局变化及意义[J].中国免疫学杂志,2006,22(6):531-534. 被引量:20
  • 4Okita R, Saeki T, Takashima S, et al. CD4^+ CD25^ + regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer [ J ]. Oncol Rep, 2005, 14(5): 1269-1273.
  • 5Wolf AM, Wolf D, Steurer M, et al. Increase of regulatory T cells in the peripheral blood of cancer patients [ J ]. Clin Cancer Res, 2003, 9(2):606-612.
  • 6Terabe M, Berzofsky JA. Immunoregulatory T cells in tumor immunity[J]. Curr Opin Immunol, 2004, 16:157-162.
  • 7Seo N, Hayakawa S, Takigawa M, et al. Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4^+ T-regulatory cells and systemic collapse of antitumour immunity [ J ]. Immunology, 2001, 103 (4):449- 457.
  • 8Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains ( CD25 ): breakdown of a single mechanism of self-toleranee causes various autoimmune diseases [J]. J Imnmnol, 1995, 155 (3): 1151-1164.
  • 9Nizar S, Copier J, Meyer B, et al. T-regulatory cell modulation: the future of cancer immunotherapy? [J]. Br J Cancer, 2009, 100 (11): 1697-1703.
  • 10Beyer M, Sehultze JL. Regulatory T cells: major players in the tumor microenvironment [J]. Curr Pharm Res, 2009, 15 (16):1879-1892.

共引文献49

同被引文献51

  • 1Zhou S, Tao H, Zhen Z, et al. Depletion of CD4 + CD25 + regulatory T cells promotes CCL21 mediated antitumor immunity. PLoS One, 2013, 8: e73952.
  • 2Huang X, Zou Y, Lian L, et al. Changes of T cells and cytokines TGF-β1 and IL-10 in mice during liver metastasis of colon carcinoma: implications for liver anti-tumor immunity. J Gastrointest Surg, 2013, 17: 1283-1291.
  • 3Cho J, Kim L, Li Z, et al. Sex bias in experimental immune- mediated, drug induced liver injury in BALB/c micec suggested roles for Tregs, estrogen, and IL-6. PLoS One, 2013, 8: e61186.
  • 4Almeida J, Polvorosa MA, Gonzalez-Quintela A, et al. Decreased peripheral blood CD4 +/CD25 + regulatory T cells in patients with alcoholic hepatitis. Alcohol Clin Exp Res, 2013, 37.- 136%1369.
  • 5Wu H, Chen P, Liao R, et al. Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients. J Gastroenterol Hepatol, 2013, 28: 1555-1564.
  • 6Yi Y, He HW, Wang JX, et al. The functional impairment of HCC-infiltrating γδ T cells, partially mediated by regulatory T cells in a TGFI3 and IL-10-dependent manner. J Hepatol, 2013, 58 : 977-983.
  • 7Cabrera R, Ararat M, Xu Y, et al. Immune modulation of efIector CD4 + and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma. Cancer Immunol Immunother, 2013, 62:737- 746.
  • 8Molina JR, Adjei AA, Jett JR. Advances in chemotherapy of non-small cell lung cancer[J]. Chest, 2006, 130:1211-1219.
  • 9Pollock RE, Lotzovi E, Stanford SD. Surgical stress impairs natural killer cell programming of tumor for lysis in patients with sarcomas and other solid tumors[J]. Cancer, 1992, 70: 2192-2202.
  • 10Zhong W, Yang X, Bai J, et al. Complete mediastinal lymphadenectomy:the core component of the multidisciplinary therapy in resectable non-small cell lung cancer [J]. Eur J Cardiothorac Surg, 2008, 34: 187-195.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部